世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Cardiotocograph (CTG) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cardiotocograph (CTG) was estimated to be worth US$ 381 million in 2024 and is forecast to a readjusted size of US$ 526 million by 2031 with a CAGR of 4.8% during the forecast... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Cardiotocograph (CTG) was estimated to be worth US$ 381 million in 2024 and is forecast to a readjusted size of US$ 526 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Cardiotocograph (CTG) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations. Cardiotocography (CTG), also known as Electronic Fetal Monitoring (EFM), which can monitor both the fetal heart rate and uterine contractions. This method provides a paper recording of the fetal heart rate and the uterine contractions, but prevents the mother from leaving the hospital bed and restricts general movement. The cardiotocograph (CTG) market is being driven by the growing global emphasis on improving maternal and fetal health outcomes. CTG is a vital prenatal monitoring technology used to assess fetal heart rate and uterine contractions during pregnancy and labor, helping healthcare providers detect fetal distress and prevent complications such as hypoxia or stillbirth. The rising global birth rate, especially in developing countries, and increasing awareness of prenatal care are boosting the demand for CTG devices. In developed regions, the adoption of advanced and digital CTG systems is fueled by technological innovations, including wireless monitoring, real-time data integration with electronic medical records, and remote patient monitoring capabilities. These innovations enhance clinical decision-making and workflow efficiency, especially in high-risk pregnancies. Additionally, government initiatives and funding aimed at reducing maternal and infant mortality—such as those led by the WHO and national health programs—are supporting the expansion of prenatal monitoring infrastructure. Private and public investments in modernizing healthcare facilities and the growing number of maternity clinics and hospitals globally also contribute to the market’s positive trajectory. Despite its benefits, the CTG market faces several challenges that could hinder broader adoption. One of the primary issues is the lack of trained healthcare professionals in many low- and middle-income countries, which limits the effective use and interpretation of CTG data. In these regions, outdated or insufficient monitoring infrastructure further hampers accurate prenatal assessment. Moreover, CTG interpretation can be subjective and prone to variability among clinicians, leading to false positives and unnecessary interventions such as cesarean sections, which raise healthcare costs and risks. There is also a growing debate in the medical community about the overuse of CTG in low-risk pregnancies, with some studies suggesting it does not significantly reduce neonatal morbidity or mortality in such cases. Additionally, the high cost of advanced CTG machines with integrated digital and telemetry functions may be prohibitive for smaller clinics and rural hospitals. Data privacy and integration concerns also arise when using cloud-based or wireless systems, especially in regions with limited digital infrastructure or unclear data protection laws. Addressing these challenges will require not only technological innovation but also investment in training, standardization of interpretation protocols, and equitable access to quality maternal healthcare. This report aims to provide a comprehensive presentation of the global market for Cardiotocograph (CTG), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cardiotocograph (CTG) by region & country, by Type, and by Application. The Cardiotocograph (CTG) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiotocograph (CTG). Market Segmentation By Company GE Healthcare Philips Healthcare Edan Instruments BIOLIGHT ArjoHuntleigh Contec Medical Systems Sunray Medical Apparatus Bionet Luckcome Medgyn Products BRAEL-Medical Equipment Medical ECONET BabyFun Yuwell HealForce Comper Segment by Type Traditional CTG Intelligent CTG Segment by Application Hospital Clinical Home By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Cardiotocograph (CTG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Cardiotocograph (CTG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Cardiotocograph (CTG) in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Cardiotocograph (CTG) Product Introduction 1.2 Global Cardiotocograph (CTG) Market Size Forecast 1.2.1 Global Cardiotocograph (CTG) Sales Value (2020-2031) 1.2.2 Global Cardiotocograph (CTG) Sales Volume (2020-2031) 1.2.3 Global Cardiotocograph (CTG) Sales Price (2020-2031) 1.3 Cardiotocograph (CTG) Market Trends & Drivers 1.3.1 Cardiotocograph (CTG) Industry Trends 1.3.2 Cardiotocograph (CTG) Market Drivers & Opportunity 1.3.3 Cardiotocograph (CTG) Market Challenges 1.3.4 Cardiotocograph (CTG) Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Cardiotocograph (CTG) Players Revenue Ranking (2024) 2.2 Global Cardiotocograph (CTG) Revenue by Company (2020-2025) 2.3 Global Cardiotocograph (CTG) Players Sales Volume Ranking (2024) 2.4 Global Cardiotocograph (CTG) Sales Volume by Company Players (2020-2025) 2.5 Global Cardiotocograph (CTG) Average Price by Company (2020-2025) 2.6 Key Manufacturers Cardiotocograph (CTG) Manufacturing Base and Headquarters 2.7 Key Manufacturers Cardiotocograph (CTG) Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Cardiotocograph (CTG) 2.9 Cardiotocograph (CTG) Market Competitive Analysis 2.9.1 Cardiotocograph (CTG) Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Cardiotocograph (CTG) Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiotocograph (CTG) as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Traditional CTG 3.1.2 Intelligent CTG 3.2 Global Cardiotocograph (CTG) Sales Value by Type 3.2.1 Global Cardiotocograph (CTG) Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Cardiotocograph (CTG) Sales Value, by Type (2020-2031) 3.2.3 Global Cardiotocograph (CTG) Sales Value, by Type (%) (2020-2031) 3.3 Global Cardiotocograph (CTG) Sales Volume by Type 3.3.1 Global Cardiotocograph (CTG) Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Cardiotocograph (CTG) Sales Volume, by Type (2020-2031) 3.3.3 Global Cardiotocograph (CTG) Sales Volume, by Type (%) (2020-2031) 3.4 Global Cardiotocograph (CTG) Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospital 4.1.2 Clinical 4.1.3 Home 4.2 Global Cardiotocograph (CTG) Sales Value by Application 4.2.1 Global Cardiotocograph (CTG) Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Cardiotocograph (CTG) Sales Value, by Application (2020-2031) 4.2.3 Global Cardiotocograph (CTG) Sales Value, by Application (%) (2020-2031) 4.3 Global Cardiotocograph (CTG) Sales Volume by Application 4.3.1 Global Cardiotocograph (CTG) Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Cardiotocograph (CTG) Sales Volume, by Application (2020-2031) 4.3.3 Global Cardiotocograph (CTG) Sales Volume, by Application (%) (2020-2031) 4.4 Global Cardiotocograph (CTG) Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Cardiotocograph (CTG) Sales Value by Region 5.1.1 Global Cardiotocograph (CTG) Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Cardiotocograph (CTG) Sales Value by Region (2020-2025) 5.1.3 Global Cardiotocograph (CTG) Sales Value by Region (2026-2031) 5.1.4 Global Cardiotocograph (CTG) Sales Value by Region (%), (2020-2031) 5.2 Global Cardiotocograph (CTG) Sales Volume by Region 5.2.1 Global Cardiotocograph (CTG) Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Cardiotocograph (CTG) Sales Volume by Region (2020-2025) 5.2.3 Global Cardiotocograph (CTG) Sales Volume by Region (2026-2031) 5.2.4 Global Cardiotocograph (CTG) Sales Volume by Region (%), (2020-2031) 5.3 Global Cardiotocograph (CTG) Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Cardiotocograph (CTG) Sales Value, 2020-2031 5.4.2 North America Cardiotocograph (CTG) Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Cardiotocograph (CTG) Sales Value, 2020-2031 5.5.2 Europe Cardiotocograph (CTG) Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Cardiotocograph (CTG) Sales Value, 2020-2031 5.6.2 Asia Pacific Cardiotocograph (CTG) Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Cardiotocograph (CTG) Sales Value, 2020-2031 5.7.2 South America Cardiotocograph (CTG) Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Cardiotocograph (CTG) Sales Value, 2020-2031 5.8.2 Middle East & Africa Cardiotocograph (CTG) Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Cardiotocograph (CTG) Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Cardiotocograph (CTG) Sales Value and Sales Volume 6.2.1 Key Countries/Regions Cardiotocograph (CTG) Sales Value, 2020-2031 6.2.2 Key Countries/Regions Cardiotocograph (CTG) Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Cardiotocograph (CTG) Sales Value, 2020-2031 6.3.2 United States Cardiotocograph (CTG) Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Cardiotocograph (CTG) Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Cardiotocograph (CTG) Sales Value, 2020-2031 6.4.2 Europe Cardiotocograph (CTG) Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Cardiotocograph (CTG) Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Cardiotocograph (CTG) Sales Value, 2020-2031 6.5.2 China Cardiotocograph (CTG) Sales Value by Type (%), 2024 VS 2031 6.5.3 China Cardiotocograph (CTG) Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Cardiotocograph (CTG) Sales Value, 2020-2031 6.6.2 Japan Cardiotocograph (CTG) Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Cardiotocograph (CTG) Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Cardiotocograph (CTG) Sales Value, 2020-2031 6.7.2 South Korea Cardiotocograph (CTG) Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Cardiotocograph (CTG) Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Cardiotocograph (CTG) Sales Value, 2020-2031 6.8.2 Southeast Asia Cardiotocograph (CTG) Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Cardiotocograph (CTG) Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Cardiotocograph (CTG) Sales Value, 2020-2031 6.9.2 India Cardiotocograph (CTG) Sales Value by Type (%), 2024 VS 2031 6.9.3 India Cardiotocograph (CTG) Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 GE Healthcare 7.1.1 GE Healthcare Company Information 7.1.2 GE Healthcare Introduction and Business Overview 7.1.3 GE Healthcare Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 GE Healthcare Cardiotocograph (CTG) Product Offerings 7.1.5 GE Healthcare Recent Development 7.2 Philips Healthcare 7.2.1 Philips Healthcare Company Information 7.2.2 Philips Healthcare Introduction and Business Overview 7.2.3 Philips Healthcare Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 Philips Healthcare Cardiotocograph (CTG) Product Offerings 7.2.5 Philips Healthcare Recent Development 7.3 Edan Instruments 7.3.1 Edan Instruments Company Information 7.3.2 Edan Instruments Introduction and Business Overview 7.3.3 Edan Instruments Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Edan Instruments Cardiotocograph (CTG) Product Offerings 7.3.5 Edan Instruments Recent Development 7.4 BIOLIGHT 7.4.1 BIOLIGHT Company Information 7.4.2 BIOLIGHT Introduction and Business Overview 7.4.3 BIOLIGHT Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 BIOLIGHT Cardiotocograph (CTG) Product Offerings 7.4.5 BIOLIGHT Recent Development 7.5 ArjoHuntleigh 7.5.1 ArjoHuntleigh Company Information 7.5.2 ArjoHuntleigh Introduction and Business Overview 7.5.3 ArjoHuntleigh Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 ArjoHuntleigh Cardiotocograph (CTG) Product Offerings 7.5.5 ArjoHuntleigh Recent Development 7.6 Contec Medical Systems 7.6.1 Contec Medical Systems Company Information 7.6.2 Contec Medical Systems Introduction and Business Overview 7.6.3 Contec Medical Systems Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Contec Medical Systems Cardiotocograph (CTG) Product Offerings 7.6.5 Contec Medical Systems Recent Development 7.7 Sunray Medical Apparatus 7.7.1 Sunray Medical Apparatus Company Information 7.7.2 Sunray Medical Apparatus Introduction and Business Overview 7.7.3 Sunray Medical Apparatus Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Sunray Medical Apparatus Cardiotocograph (CTG) Product Offerings 7.7.5 Sunray Medical Apparatus Recent Development 7.8 Bionet 7.8.1 Bionet Company Information 7.8.2 Bionet Introduction and Business Overview 7.8.3 Bionet Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Bionet Cardiotocograph (CTG) Product Offerings 7.8.5 Bionet Recent Development 7.9 Luckcome 7.9.1 Luckcome Company Information 7.9.2 Luckcome Introduction and Business Overview 7.9.3 Luckcome Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Luckcome Cardiotocograph (CTG) Product Offerings 7.9.5 Luckcome Recent Development 7.10 Medgyn Products 7.10.1 Medgyn Products Company Information 7.10.2 Medgyn Products Introduction and Business Overview 7.10.3 Medgyn Products Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 Medgyn Products Cardiotocograph (CTG) Product Offerings 7.10.5 Medgyn Products Recent Development 7.11 BRAEL-Medical Equipment 7.11.1 BRAEL-Medical Equipment Company Information 7.11.2 BRAEL-Medical Equipment Introduction and Business Overview 7.11.3 BRAEL-Medical Equipment Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 BRAEL-Medical Equipment Cardiotocograph (CTG) Product Offerings 7.11.5 BRAEL-Medical Equipment Recent Development 7.12 Medical ECONET 7.12.1 Medical ECONET Company Information 7.12.2 Medical ECONET Introduction and Business Overview 7.12.3 Medical ECONET Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 Medical ECONET Cardiotocograph (CTG) Product Offerings 7.12.5 Medical ECONET Recent Development 7.13 BabyFun 7.13.1 BabyFun Company Information 7.13.2 BabyFun Introduction and Business Overview 7.13.3 BabyFun Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 BabyFun Cardiotocograph (CTG) Product Offerings 7.13.5 BabyFun Recent Development 7.14 Yuwell 7.14.1 Yuwell Company Information 7.14.2 Yuwell Introduction and Business Overview 7.14.3 Yuwell Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Yuwell Cardiotocograph (CTG) Product Offerings 7.14.5 Yuwell Recent Development 7.15 HealForce 7.15.1 HealForce Company Information 7.15.2 HealForce Introduction and Business Overview 7.15.3 HealForce Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.15.4 HealForce Cardiotocograph (CTG) Product Offerings 7.15.5 HealForce Recent Development 7.16 Comper 7.16.1 Comper Company Information 7.16.2 Comper Introduction and Business Overview 7.16.3 Comper Cardiotocograph (CTG) Sales, Revenue, Price and Gross Margin (2020-2025) 7.16.4 Comper Cardiotocograph (CTG) Product Offerings 7.16.5 Comper Recent Development 8 Industry Chain Analysis 8.1 Cardiotocograph (CTG) Industrial Chain 8.2 Cardiotocograph (CTG) Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Cardiotocograph (CTG) Sales Model 8.5.2 Sales Channel 8.5.3 Cardiotocograph (CTG) Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社の 医療機器・消耗品分野 での最新刊レポート
本レポートと同じKEY WORD（demand）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
